Skip to content

AI Medical Intelligence

Virtual Scribe vs Ambient AI: 2027 EBITDA Comparison

2027 EBITDA analysis: ambient AI documentation vs virtual scribes, labor cost deltas, CPT G2211 capture, and 10-provider practice margin impact.

Book a demo✦
11 min read
Medical AI, Ambient Scribe, Intelligence
COMPLIANCEAUDIT-READYDISCLOSUREATTESTATION

Virtual Scribe Services vs Ambient AI Documentation: 2027 Clinic EBITDA Comparison Playbook

Merry AI · Thoughtfully curated clinical briefs.

Clinically reviewed by Dr. Marcus Vance, MD (Medical Informatics Advisor) · Coding review by Kaif R. (Clinical Informatics Specialist) · Sources: CY 2026 CMS PFS, NCCI Policy Manual.

Ambient AI documentation outperforms virtual scribe services on clinic EBITDA for 2027. It replaces an estimated $12,000 to $36,000 annual per-provider scribe labor expense with a software line item that can cost as little as $648 per year. It also preserves the medical decision making (MDM) detail that E/M leveling and CPT G2211 require. For a ten-provider practice, that difference can move more than $230,000 per year from operating expense into EBITDA before any revenue capture gains.

This playbook gives practice administrators and CMOs a defensible financial model, a clinical documentation benchmark built on heart failure visits, and an audit and statutory checklist. Use it to decide whether to retain, reduce, or replace virtual scribe contracts in the 2027 budget cycle.

Key benchmark: Merry AI Pro equals 1.3% of one $48,000 medical assistant.

Ambient AI cuts per-provider documentation cost by over 95% versus virtual scribes

Virtual scribe services bill as labor, not software. Domestic remote scribes are typically quoted at $2,000 to $3,000 per provider per month, and offshore models commonly run $1,000 to $1,500. Those costs scale linearly with headcount, clinic hours, and turnover backfill. Ambient AI platforms bill per seat, and costs stay flat whether a clinician sees 14 or 24 patients per day.

The table below summarizes observed 2026 market ranges. Vendor quotes vary by volume, specialty, and contract term, so treat these figures as modeling inputs rather than fixed prices.

Documentation modelTypical monthly cost per providerAnnual cost per providerShare of $48,000 MA denominatorScaling behavior
In-room MA acting as scribeAbout $4,000$48,000 (fully loaded)100%Linear; vacancy and turnover risk
Domestic virtual scribe service$2,000 to $3,000$24,000 to $36,00050% to 75%Linear; per-hour or per-provider billing
Offshore virtual scribe service$1,000 to $1,500$12,000 to $18,00025% to 38%Linear; time zone and data residency exposure
Enterprise ambient AI platform$300 to $600$3,600 to $7,2007.5% to 15%Flat per seat; integration fees often extra
Merry AI Pro (annual plan)$54$6481.3%Flat per seat; browser overlay, no EHR build

A $48,000 fully loaded MA sets the 2027 labor denominator

Use the medical assistant as the denominator because it is the cost most clinics actually absorb when scribe coverage lapses. A $48,000 fully loaded figure includes wages, payroll taxes, benefits, training, and paid time off. When a practice pulls an MA into the exam room to document, it loses rooming throughput, inbox management, and prior authorization capacity.

Merry AI Pro at $54 per month, billed annually, costs $648 per provider per year. That is 1.3% of the $48,000 MA denominator. Put another way, one MA's annual cost funds ambient documentation for roughly 74 clinicians, so MAs can return to work that generates revenue.

Budget rule: compare every documentation option against the $48,000 MA denominator.

CY 2026 PFS changes make documentation cost a primary 2027 EBITDA lever

The CY 2026 Physician Fee Schedule introduced two conversion factors: $33.4009 for clinicians who are not qualifying APM participants and $33.5675 for those who are. It also applied a 2.5% efficiency adjustment to work RVUs for non-time-based services. That adjustment reduces valuations for many procedures and diagnostic services while leaving office E/M visits largely protected.

The one-year 2.5% statutory payment increase for CY 2026 is scheduled to expire for 2027 unless Congress acts. Practices should model flat to modestly negative Medicare revenue per RVU for 2027. When top-line growth stalls, fixed labor contracts such as virtual scribe services compress margin directly. That makes documentation cost one of the few controllable EBITDA levers.

G2211 capture adds $15,600+ annual revenue per provider with documented longitudinal care

CPT G2211 is an add-on code for visit complexity inherent to office and outpatient E/M services. It applies when the practitioner serves as the continuing focal point for all needed services, or provides ongoing care for a single serious or complex condition. Its national payment is approximately $16 per claim. Since CY 2025, it has been payable alongside modifier 25 when the separately reported service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service.

The $15,600+ recovery figure reflects roughly 975 eligible Medicare visits per provider per year, or about 20 per week, at approximately $16 each. Most practices under-capture G2211 because notes do not state the longitudinal relationship explicitly. See the CPT G2211 Complexity Capture Architecture for documentation prompts that tie the add-on to the assessment and plan.

Virtual scribes can capture G2211 when they are trained, but accuracy depends on individual scribe retention and coding education. Ambient AI applies the same documentation logic on every encounter. That consistency is what turns G2211 from a sporadic add-on into a predictable revenue line.

G2211 requires explicit longitudinal relationship language, not an implied continuity statement.

Heart failure visits show how MDM documentation separates 99214 from 99215

Chronic systolic heart failure, coded as I50.22 (ICD-10-CM), is a useful benchmark because the E/M level depends on documented reasoning rather than visit length. A stable patient on guideline-directed medical therapy with prescription drug management supports moderate MDM (99214). A severe exacerbation, a decision regarding hospitalization, or drug therapy requiring intensive monitoring for toxicity can support high MDM (99215).

Unspecified cardiomyopathy, coded as I42.9 (ICD-10-CM), is a frequent specificity gap. When echocardiography or clinical history supports dilated (I42.0) or ischemic (I25.5) cardiomyopathy, the note should say so. Specific coding strengthens medical necessity and risk adjustment accuracy, and it reduces payer queries.

Human scribes often document what they hear in summary form. A clinician's verbal reasoning about whether to titrate sacubitril/valsartan, add an SGLT2 inhibitor, or adjust spironolactone based on potassium and creatinine trends is easy to compress into one line. Ambient AI preserves that reasoning, which is the evidence an auditor needs to validate the MDM risk element.

Clinical indicators, MDM thresholds, and audit defenses differ by documentation model

Clinical indicatorMDM element and thresholdVirtual scribe riskAmbient AI captureAudit defense
Stable HFrEF (I50.22) on GDMT, LVEF 40% or belowChronic illness plus prescription drug management: moderate (99214)Medication rationale reduced to "continue meds"Captures dose, tolerance, and titration decisionMedication reconciliation and explicit titration rationale
Weight gain of 2 to 3 lb overnight or 5 lb in a week, worsening NYHA classChronic illness with exacerbation (moderate); severe exacerbation (high)Severity descriptors omitted or generalizedRecords symptom trajectory and exam findings verbatimObjective trend data: weights, edema grade, NT-proBNP
MRA or loop diuretic with potassium and creatinine labsDrug therapy requiring intensive monitoring for toxicity: high riskLab purpose not linked to toxicity monitoringLinks lab orders to adverse effect surveillanceStatement that labs assess toxicity, with monitoring interval
Unspecified cardiomyopathy (I42.9)Diagnosis specificity supporting problem complexityDefaults to unspecified codeSurfaces echo findings that support specific etiologyDocumented etiology (dilated, ischemic) or query trail
Independent review of ECG or echocardiogramData element: independent interpretation of a testInterpretation not separated from the result summaryAttributes interpretation to the rendering clinicianClinician's own interpretation, not the report text
Decompensation requiring admission discussionDecision regarding hospitalization: high riskShared decision dialogue condensedCaptures options discussed and patient preferenceDocumented alternatives and reason for the chosen setting
Continuing focal point for HF careG2211 longitudinal relationship (add-on)Relationship implied, not statedPrompts explicit longitudinal relationship statementRelationship statement tied to the assessment and plan

Audit defense depends on provider authentication, not on who drafts the note

CMS evaluates the signed note, not the drafting method. Under CMS Program Integrity Manual signature requirements, the billing practitioner must authenticate the documentation. Whether a remote scribe or an ambient AI model produced the draft, the rendering clinician owns the content, and unreviewed drafts are a compliance liability in both models.

Cloned documentation is the shared audit risk. Templated scribe notes and poorly configured AI outputs can both produce identical language across encounters, which auditors flag as insufficient evidence of individualized medical necessity. Practices should require encounter-specific assessment language and keep edit logs that show clinician review.

NCCI Policy Manual guidance on E/M services also governs modifier 25. A significant, separately identifiable E/M service must be supported by documentation that stands apart from the procedure or preventive service. Ambient capture helps here because it records the separate clinical problem discussion in the clinician's own words.

  • Retain attestation timestamps for every signed encounter.
  • Preserve edit trails showing clinician modifications to the AI or scribe draft.
  • Audit 10 notes per provider quarterly for cloned language and MDM support.
  • Track G2211 and modifier 25 pairing against CY 2025 and CY 2026 eligibility rules.

State AI scribe statutes impose disclosure and consent duties on both models

Recording consent applies to both virtual scribes listening in real time and ambient AI capturing audio. All-party consent states, including California, Florida, Illinois, Maryland, Massachusetts, Pennsylvania, and Washington, require every participant's agreement before an encounter is recorded or monitored. Clinics should standardize a verbal consent script and a structured consent flag in the chart.

AI-specific statutes add a second layer. California AB 3030 requires disclaimers on generative AI patient communications unless a licensed clinician reviews them. Texas SB 1188 requires practitioners who use AI in diagnosis or treatment to review AI-generated records and disclose AI use to patients. Track jurisdiction-specific requirements through the State AI Scribe Rules & Statutory Compliance Hub.

California SB 1120 raises the value of human-attested clinical documentation

California SB 1120 requires that health plan medical necessity determinations be made by a licensed physician or qualified health care provider, not by an algorithm alone. The law governs payers, not clinics. Even so, it means denials and appeals in California increasingly turn on whether a human reviewer can find clear, clinician-attested reasoning in the record.

Complete MDM documentation is the clinic's best defense in that review. Notes that capture exacerbation severity, monitoring rationale, and hospitalization decisions reduce peer-to-peer escalations and denial rework, which is an EBITDA cost that rarely appears in scribe ROI models.

Browser overlay architecture avoids EHR integration fees that erode EBITDA

Enterprise ambient AI contracts often carry implementation fees, EHR vendor marketplace charges, and interface maintenance costs that are not reflected in the per-seat price. Deep integrations can also take months of IT scheduling before clinicians see value, which delays the EBITDA effect into a later fiscal year.

A browser overlay works on top of the existing EHR session without a custom interface build, so deployment is measured in days. Review the tradeoffs in EHR Browser Overlay Architecture, including how FHIR R4 US Core resources support structured data exchange where an API connection is warranted.

A ten-provider clinic can shift over $230,000 annually into EBITDA

Model the baseline with care. Ten providers using a domestic virtual scribe service at $2,000 per month cost $240,000 per year. Ten Merry AI Pro seats cost $6,480 per year. The direct operating expense reduction is $233,520, which flows to EBITDA dollar for dollar if scribe contracts are fully retired.

Layer G2211 recovery separately. If those ten providers currently under-capture G2211, consistent longitudinal documentation can add up to $156,000 per year ($15,600+ per provider). Combined, the potential EBITDA improvement approaches $390,000 annually. Discount the G2211 figure in proportion to current capture rates and Medicare panel mix.

Account for transition costs honestly. Budget for two to four weeks of clinician adoption time, template configuration, and a compliance review of consent workflows. Some clinics keep limited virtual scribe coverage for high-acuity procedural sessions or for clinicians who need extensive interpretation support. A hybrid model still captures most of the savings.

Model G2211 revenue separately from labor savings to keep projections defensible.

The 2027 decision framework prioritizes cost, MDM fidelity, and statutory compliance

  1. Calculate your true scribe cost per provider, including turnover backfill and overtime.
  2. Benchmark against the $48,000 MA denominator and the $648 Merry AI Pro seat.
  3. Audit 20 chronic disease notes for MDM support, specificity, and G2211 language.
  4. Map recording consent and AI disclosure duties for every state you practice in.
  5. Pilot ambient AI with three to five high-volume clinicians for 30 days.
  6. Measure note closure time, E/M distribution, G2211 capture rate, and denial rate.
  7. Time scribe contract renewals to the pilot results before the 2027 budget lock.

Frequently asked questions about virtual scribes versus ambient AI EBITDA

Are ambient AI scribes cheaper than virtual scribe services?

Yes. Remote human scribe services typically cost $1,500 to $3,000 per provider monthly, while ambient AI platforms range from about $54 to $600 monthly. Merry AI Pro costs $648 per year, roughly 1.3% of a $48,000 fully loaded medical assistant, shifting most documentation spend directly into EBITDA.

Does ambient AI documentation support CPT G2211 billing?

Ambient AI supports G2211 when the note documents the longitudinal relationship: the practitioner as continuing focal point for all needed services or ongoing care for a single serious condition. Capturing that context consistently can recover $15,600 or more annually per provider, assuming roughly 975 eligible Medicare visits.

Who is legally responsible for an AI-drafted or scribe-drafted note?

The rendering clinician is responsible in both models. CMS requires the billing practitioner to review, edit, and authenticate the documentation, and auditors evaluate the signed note, not the drafting method. Practices should retain attestation logs, edit trails, and timestamps to defend medical necessity during payer or RAC review.

Do state laws require patient consent for ambient AI documentation?

Many do. Two-party consent states, including California, Florida, Illinois, Pennsylvania, and Washington, require all parties to agree before recording, which generally applies to virtual scribes and ambient AI alike. Texas and California add AI disclosure duties, so clinics should standardize verbal consent and chart a consent flag.

How will 2027 Medicare payment changes affect scribe ROI?

Absent new Congressional action, the one-year 2.5% CY 2026 payment increase expires for 2027, and the 2.5% efficiency adjustment to non-time-based services remains embedded. Flat or declining reimbursement makes fixed scribe labor harder to absorb, strengthening the EBITDA case for low-cost ambient AI with complexity capture.

Merry AI TeamClinical Intelligence Team
11 min read